• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体随机分组治疗试验和当受试者属于多个组时的整群随机试验的分析方法。

Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups.

机构信息

Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, 43210, U.S.A.

出版信息

Stat Med. 2014 Jun 15;33(13):2178-90. doi: 10.1002/sim.6083. Epub 2014 Jan 8.

DOI:10.1002/sim.6083
PMID:24399701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4013262/
Abstract

Participants in trials may be randomized either individually or in groups and may receive their treatment either entirely individually, entirely in groups, or partially individually and partially in groups. This paper concerns cases in which participants receive their treatment either entirely or partially in groups, regardless of how they were randomized. Participants in group-randomized trials are randomized in groups, and participants in individually randomized group treatment trials are individually randomized, but participants in both types of trials receive part or all of their treatment in groups or through common change agents. Participants who receive part or all of their treatment in a group are expected to have positively correlated outcome measurements. This paper addresses a situation that occurs in group-randomized trials and individually randomized group treatment trials-participants receive treatment through more than one group. As motivation, we consider trials in The Childhood Obesity Prevention and Treatment Research Consortium, in which each child participant receives treatment in at least two groups. In simulation studies, we considered several possible analytic approaches over a variety of possible group structures. A mixed model with random effects for both groups provided the only consistent protection against inflated type I error rates and did so at the cost of only moderate loss of power when intraclass correlations were not large. We recommend constraining variance estimates to be positive and using the Kenward-Roger adjustment for degrees of freedom; this combination provided additional power but maintained type I error rates at the nominal level.

摘要

参与者可以个体或群体随机分组,并且可以接受完全个体治疗、完全群体治疗或部分个体和部分群体治疗。本文关注的是无论参与者如何随机分组,他们都接受完全或部分群体治疗的情况。群体随机试验中的参与者是按群体随机分组的,个体随机分组治疗试验中的参与者是个体随机分组的,但这两种类型的试验中的参与者都通过共同的改变因素接受部分或全部群体治疗。接受部分或全部群体治疗的参与者的结果测量预计会存在正相关。本文解决了群体随机试验和个体随机分组治疗试验中出现的一种情况——参与者通过多个群体接受治疗。作为动机,我们考虑了“儿童肥胖预防和治疗研究联盟”中的试验,每个儿童参与者都在至少两个组中接受治疗。在模拟研究中,我们考虑了多种可能的群体结构下的几种可能的分析方法。对于组间随机效应的混合模型提供了唯一的一致保护,防止了 I 型错误率膨胀,并且在组内相关系数不大时,仅以适度的损失功效为代价。我们建议将方差估计约束为正,并使用肯沃德-罗杰自由度调整;这种组合提供了额外的功效,但将 I 型错误率保持在名义水平。

相似文献

1
Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups.个体随机分组治疗试验和当受试者属于多个组时的整群随机试验的分析方法。
Stat Med. 2014 Jun 15;33(13):2178-90. doi: 10.1002/sim.6083. Epub 2014 Jan 8.
2
Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.个体随机分组治疗试验:对常用设计和分析方法的批判性评价
Am J Public Health. 2008 Aug;98(8):1418-24. doi: 10.2105/AJPH.2007.127027. Epub 2008 Jun 12.
3
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Analysis of multiple-period group randomized trials: random coefficients model or repeated measures ANOVA?多周期群组随机试验分析:随机系数模型还是重复测量方差分析?
Trials. 2022 Dec 7;23(1):987. doi: 10.1186/s13063-022-06917-2.
6
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs.评价嵌套和交叉设计中具有复杂聚类的个体随机分组治疗试验的分析模型。
Stat Med. 2024 Nov 10;43(25):4796-4818. doi: 10.1002/sim.10206. Epub 2024 Sep 3.
7
The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.群组随机交叉试验:AB/BA 设计中损耗的影响及其在样本量计算中的处理方法。
Clin Trials. 2020 Aug;17(4):420-429. doi: 10.1177/1740774520913042. Epub 2020 Mar 19.
8
Improving the efficiency of individually randomized clinical trials by staggering the introduction of the intervention.通过交错引入干预措施来提高个体随机临床试验的效率。
Stat Med. 2019 Jan 15;38(1):44-52. doi: 10.1002/sim.7959. Epub 2018 Sep 17.
9
Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.在小样本整群随机试验中分析二元结局时比较广义线性混合模型的分母自由度近似值。
BMC Med Res Methodol. 2015 Apr 23;15:38. doi: 10.1186/s12874-015-0026-x.
10
Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures.治疗组间异方差性对重复测量混合效应模型的影响。
Pharm Stat. 2018 Sep;17(5):578-592. doi: 10.1002/pst.1872. Epub 2018 Jul 6.

引用本文的文献

1
Implementation Research at NHLBI: Methodological and Design Challenges and Lessons Learned from the DECIPHeR Initiative.NHLBI 的实施研究:从 DECIPHeR 计划中汲取的方法学和设计挑战及经验教训。
Ethn Dis. 2024 Apr 24;DECIPHeR(Spec Issue):12-17. doi: 10.18865/ed.DECIPHeR.12. eCollection 2023 Dec.
2
Randomization, design and analysis for interdependency in aging research: no person or mouse is an island.衰老研究中相互依存性的随机化、设计和分析:没有人或老鼠是一座孤岛。
Nat Aging. 2022 Dec;2(12):1101-1111. doi: 10.1038/s43587-022-00333-6. Epub 2022 Dec 22.
3
Accounting for Context in Randomized Trials after Assignment.分配后随机试验中考虑上下文因素
Prev Sci. 2022 Nov;23(8):1321-1332. doi: 10.1007/s11121-022-01426-9. Epub 2022 Sep 9.
4
Influential methods reports for group-randomized trials and related designs.有影响力的群组随机试验及相关设计的方法报告。
Clin Trials. 2022 Aug;19(4):353-362. doi: 10.1177/17407745211063423. Epub 2022 Jan 6.
5
Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.在阿尔茨海默病和相关痴呆症的实用临床试验中方法学面临的挑战:改进的机会。
Clin Trials. 2022 Feb;19(1):86-96. doi: 10.1177/17407745211046672. Epub 2021 Nov 29.
6
ACTonFood. Acceptance and Commitment Therapy-Based Group Treatment Compared to Cognitive Behavioral Therapy-Based Group Treatment for Weight Loss Maintenance: An Individually Randomized Group Treatment Trial.基于接受与承诺疗法的团体治疗与基于认知行为疗法的团体治疗用于体重维持的比较:一项个体随机分组治疗试验
Int J Environ Res Public Health. 2021 Sep 10;18(18):9558. doi: 10.3390/ijerph18189558.
7
Power and Sample Size for Fixed-Effects Inference in Reversible Linear Mixed Models.可逆线性混合模型中固定效应推断的功效与样本量
Am Stat. 2019;73(4):350-359. doi: 10.1080/00031305.2017.1415972. Epub 2018 Jun 4.
8
Review of Recent Methodological Developments in Group-Randomized Trials: Part 2-Analysis.群组随机试验近期方法学进展综述:第2部分——分析
Am J Public Health. 2017 Jul;107(7):1078-1086. doi: 10.2105/AJPH.2017.303707. Epub 2017 May 18.
9
Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.群组随机试验近期方法学进展综述:第1部分——设计
Am J Public Health. 2017 Jun;107(6):907-915. doi: 10.2105/AJPH.2017.303706. Epub 2017 Apr 20.
10
Coping with persistent pain, effectiveness research into self-management (COPERS): statistical analysis plan for a randomised controlled trial.应对持续性疼痛,自我管理的有效性研究(COPERS):一项随机对照试验的统计分析计划。
Trials. 2014 Feb 15;15:59. doi: 10.1186/1745-6215-15-59.

本文引用的文献

1
Assessing potential sources of clustering in individually randomised trials.评估个体随机试验中聚集现象的潜在来源。
BMC Med Res Methodol. 2013 Apr 16;13:58. doi: 10.1186/1471-2288-13-58.
2
Avoiding bias in mixed model inference for fixed effects.避免混合模型推断中固定效应的偏差。
Stat Med. 2011 Sep 30;30(22):2696-707. doi: 10.1002/sim.4293. Epub 2011 Jul 12.
3
Ignoring the group in group-level HIV/AIDS intervention trials: a review of reported design and analytic methods.忽视群组水平 HIV/AIDS 干预试验中的群组:对报告的设计和分析方法的综述。
AIDS. 2011 Apr 24;25(7):989-96. doi: 10.1097/QAD.0b013e3283467198.
4
Evaluating Group-Based Interventions When Control Participants Are Ungrouped.当对照参与者未分组时评估基于小组的干预措施。
Multivariate Behav Res. 2008 Apr 2;43(2):210-236. doi: 10.1080/00273170802034810.
5
Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.个体随机分组治疗试验:对常用设计和分析方法的批判性评价
Am J Public Health. 2008 Aug;98(8):1418-24. doi: 10.2105/AJPH.2007.127027. Epub 2008 Jun 12.
6
Design and analysis of group-randomized trials in cancer: a review of current practices.癌症群组随机试验的设计与分析:当前实践综述
J Natl Cancer Inst. 2008 Apr 2;100(7):483-91. doi: 10.1093/jnci/djn066. Epub 2008 Mar 25.
7
Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.聚类而不慌乱:相关结果对随机临床试验推断的影响。
Stat Med. 2008 Mar 15;27(6):795-809. doi: 10.1002/sim.2977.
8
The use of random effects models to allow for clustering in individually randomized trials.在个体随机试验中使用随机效应模型以考虑聚类情况。
Clin Trials. 2005;2(2):163-73. doi: 10.1191/1740774505cn082oa.
9
Design and analysis of clinical trials with clustering effects due to treatment.因治疗产生聚类效应的临床试验设计与分析
Clin Trials. 2005;2(2):152-62. doi: 10.1191/1740774505cn076oa.
10
Methods to reduce the impact of intraclass correlation in group-randomized trials.降低组群随机试验中组内相关性影响的方法。
Eval Rev. 2003 Feb;27(1):79-103. doi: 10.1177/0193841X02239019.